Investor Overview
2020
1
1
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Team (3)
| Name | Title | Board Position(s) | Contact | |
|---|---|---|---|---|
 | ㅤGeorge Petrocheilos | Managing Partner | 1 | |
 | ㅤR. Jacob Vogelstein | Managing Partner | 1 | |
 | ㅤTom V. Brooks | General Partner | 1 |
Portfolio (1)
| Company Name | Status | Founded | Sector | Funding ($) | |
|---|---|---|---|---|---|
 | ㅤImmunai | Active | 2019 | Healthcare, Life Sciences | $295M |
Funding Rounds (1)
| Round | Date | Investors | |
|---|---|---|---|
 | ㅤImmunai raises $60 million series A | February 2021 | 6 |
Funds (0)
Co-Investors (5)
| Investor Name | Investor Type | Founded | Portfolio | |
|---|---|---|---|---|
 | ㅤViola Ventures | Venture Capital | 2000 | 50 |
 | ㅤTLV Partners | Venture Capital | 2015 | 34 |
 | ㅤSchusterman Family Investments | Family Office | 1987 | 8 |
| ㅤDuquesne Family | Family Office | 2010 | 2 | |
 | ㅤDexcel Pharma | Company | 1968 | 2 |
